Shares of Calian Group Ltd. (TSE:CGY – Get Free Report) have received a consensus recommendation of “Buy” from the eight research firms that are currently covering the company, MarketBeat.com reports. Eight research analysts have rated the stock with a buy recommendation. The average 1-year target price among brokerages that have issued a report on the stock in the last year is C$87.94.
CGY has been the subject of a number of research reports. Ventum Financial lifted their target price on Calian Group from C$84.00 to C$94.00 and gave the company a “buy” rating in a research note on Tuesday, March 10th. Stifel Nicolaus set a C$100.00 price objective on Calian Group and gave the stock a “buy” rating in a research report on Wednesday. Canaccord Genuity Group boosted their price objective on Calian Group from C$63.00 to C$80.00 in a research report on Friday, February 13th. Canadian Imperial Bank of Commerce boosted their price objective on Calian Group from C$76.00 to C$90.00 in a research report on Friday, May 15th. Finally, Acumen Capital boosted their price objective on Calian Group from C$70.00 to C$85.00 and gave the stock a “buy” rating in a research report on Friday, February 13th.
Check Out Our Latest Research Report on CGY
Calian Group Stock Performance
Calian Group (TSE:CGY – Get Free Report) last issued its earnings results on Thursday, May 14th. The company reported C$1.30 EPS for the quarter. Calian Group had a return on equity of 10.35% and a net margin of 3.97%.The company had revenue of C$228.70 million during the quarter. As a group, analysts anticipate that Calian Group will post 4.9475219 EPS for the current year.
Calian Group Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 10th. Stockholders of record on Wednesday, June 10th will be given a dividend of $0.28 per share. The ex-dividend date is Wednesday, May 27th. This represents a $1.12 annualized dividend and a dividend yield of 1.3%. Calian Group’s payout ratio is currently 39.30%.
Calian Group Company Profile
Calian Group Ltd operates through four segments namely Advanced Technologies, Health, Learning, and Information Technology. It generates maximum revenue from the Health segment. The company serves health, defence, security, aerospace, engineering, AgTech, and IT industries. Its Health segment includes Clinical Services; Nursing Services; Psychological Services and Medical Property Management. The Advanced Technologies segment includes Engineering Solutions and Services; Nuclear and Environmental Services; Satcom; DOCSIS; Electronics Design and Manufacturing and Agricultural Technology.
See Also
- Five stocks we like better than Calian Group
- Workday Validates AI Flywheel: Stock Price Recovery Begins
- HubSpot at 2019 Levels Is an Opportunity—Not a Warning
- Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus?
- Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally
Receive News & Ratings for Calian Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calian Group and related companies with MarketBeat.com's FREE daily email newsletter.
